HALOCHONDRIN-B-ANALOGA

European patent · EP2274309 · In force

Register entry

Publication number
EP2274309
Application number
EP09728603
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 3, 2009
Published
Jan 19, 2011
Granted
Jul 29, 2015
Protection ends at the latest
Apr 2, 2029
Next annual fee due
Apr 30, 2027
IPC classes
C07D 493/22 (2006.01)
A61K 31/366 (2006.01)
A61P 35/00 (2006.01)
Priority
US 71111 11.04.2008
US 42643 04.04.2008
PCT application
PCT/US2009/039432 03.04.2009
PCT publication
WO2009/124237 08.10.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jul 29, 2015

    Granted

    Published in Swissreg on 29.07.2015

Parties

Holder

Eisai R&D Management Co., Ltd.

6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, JP

Inventor

HU, Yongbo

Westborought, MA, 01581, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.